KAHR Medical
Fusion Proteins for Treating Cancer and Autoimmune Diseases
Active
F
Startup
Modi'in-Maccabim-Re'ut
Founded 2005-09
KAHR is developing immuno-oncology drug candidates for the treatment of multiple types of cancer. Its lead product, DSP107, is a CD47x41BB targeting compound that simultaneously targets cancer cells, weakens their innate defenses, and activates an effective local response of both innate and adaptive immunity. KAHRs technology platform is based on multifunct…
SectorHealth Tech & Life Sciences
StageF
Total raised$117.5M
Employees25
Founded2005-09
HQModi'in-Maccabim-Re'ut
Crunchbasekahr-medical
Patents1
Confidence91
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals